Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment
Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment · Investor's Business Daily

In This Article:

Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record low.